Bulk Pharmaceutical API Sources for PRIMACOR

Bulk Pharmaceutical API Sources for PRIMACOR

Vendor	Vendor Homepage	Vendor Sku	API Url
Sigma-Aldrich		M4659_SIGMA
TCI (Tokyo Chemical Industry)		M1663
Molport		MolPort-003-666-840
Hangzhou APIChem Technology		AC-4730
Amadis Chemical		A839417
BioChemPartner		BCP0726000256
TimTec		SBB055743

Bulk Active Pharmaceutical Ingredient (API) Sources for PRIMACOR

Last updated: July 28, 2025

---

Introduction

Primacor, known generically as milrinone lactate, is a pharmaceutical compound used primarily for short-term management of congestive heart failure and cardiogenic shock. As a critical inotropic agent, it enhances cardiac output by increasing myocardial contractility and decreasing preload and afterload. Ensuring a reliable and high-quality supply chain for its active pharmaceutical ingredient (API), milrinone lactate, is vital for manufacturers and healthcare providers. This article delineates the global API sources for Primacor, emphasizing supply dynamics, industry players, and quality considerations.

---

Overview of Milrinone Lactate as an API

Milrinone lactate is a phosphodiesterase 3 (PDE3) inhibitor with potent inotropic and vasodilatory effects. Its synthesis involves complex organic chemistry processes requiring specific intermediates and catalysts. The API is typically produced under stringent Good Manufacturing Practices (GMP), ensuring safety, efficacy, and consistent quality.

The API's manufacturing process involves multiple chemical synthesis steps, often utilizing intermediates like 1,2,3,4-tetrahydro-6,7-dimethoxy-4-(4-methoxyphenyl)-2-methyl-isoquinoline-3-carboxylic acid and subsequent lactone formation.

---

Key Global Sources of Milrinone API

1. Major API Manufacturers and Suppliers

a) Domestic Chinese Suppliers

China remains a leading producer of pharmaceutical APIs due to its extensive chemical manufacturing infrastructure, cost advantages, and capacity. Several Chinese firms supply milrinone lactate API to global markets, including:

• Zhejiang Hisoar Pharmaceutical Co., Ltd.
  Specialized in cardiovascular APIs, including milrinone lactate, with GMP-certified facilities serving international markets.

• Hengyang High Tech Zone Pharmaceutical Co., Ltd.
  Offers comprehensive API manufacturing, including PDE3 inhibitors like milrinone lactate, adhering to international quality standards.

• Shandong Xinhua Pharmaceutical Co., Ltd.
  Known for producing various cardiac drugs and APIs, with capacity scaled for export.

b) Indian API Producers

India's robust pharmaceutical sector supplies high-quality APIs with a focus on compliance with international standards. Notable Indian manufacturers include:

• Divi’s Laboratories Limited
  Known globally for its high-quality APIs, including specialized cardiovascular APIs like milrinone lactate, with stringent quality controls.

• Glenmark Pharmaceuticals
  Produces APIs and intermediates, including formulations and select APIs for cardiovascular indications.

• Suven Life Sciences
  Engages in synthesis of complex APIs, with capacity for milrinone lactate.

c) European and U.S. API Manufacturers

While fewer in number, several European and U.S. firms produce APIs either domestically or through strategic partnerships:

• Piramal Pharma Solutions (India, with facilities serving international clients)
  Offers contract manufacturing services for APIs, including milrinone lactate, with a focus on quality certifications such as cGMP.

• Barnet Pharmaceuticals (U.S.)
  Provides specialized active ingredients, including cardiovascular APIs, adhering to U.S. FDA standards.

---

Supply Dynamics and Industry Trends

a) Manufacturing Concentration and Supply Security

Although multiple suppliers exist, the API market for milrinone lactate is relatively concentrated, with Chinese and Indian producers dominating due to manufacturing economies of scale. Recent trends indicate increased focus on diversifying supply sources to mitigate geopolitical risks and ensure uninterrupted supply chains.

b) Quality and Regulatory Compliance

Regulatory agencies such as the FDA, EMA, and PMDA scrutinize API manufacturing for compliance, robust stability profiles, and consistent purity. Suppliers with ISO certification, and those approved under stringent regulatory regimes, tend to be preferred by pharmaceutical companies manufacturing Primacor.

c) Impact of Global Supply Chain Disruptions

The COVID-19 pandemic underscored vulnerabilities within API supply chains, prompting pharmaceutical firms to adopt dual sourcing strategies and seek suppliers with proven manufacturing resilience. This shift is influencing procurement strategies for milrinone lactate API.

---

Key Considerations for API Sourcing

• Regulatory standards: Ensure suppliers comply with cGMP, ISO certifications, and have documented quality control measures.

• Supply reliability: Evaluate historical production volumes, lead times, and geopolitical stability of sourcing regions.

• Cost factors: Balance manufacturing costs against quality assurance; consider long-term strategic partnerships.

• Traceability: Preference for suppliers offering full supply chain transparency and batch tracking.

---

Regulatory and Quality Certification

API suppliers for Primacor should typically hold certifications such as:

• FDA Drug Master File (DMF) for U.S. market compliance
• EC GMP Certification for European Union markets
• ISO 9001/ISO 13485 Certification ensuring quality management systems
• Pharmacopoeial compliance (USP, EP, JP) for raw material specifications

---

Conclusion: sourcing outlook for Primacor API

Securing a high-quality, reliable supply of milrinone lactate API hinges on collaboration with reputed manufacturers across China, India, and established markets like Europe and the U.S. While Chinese and Indian producers dominate due to capacity and cost efficiencies, increasing emphasis on regulatory compliance and supply chain resilience encourages diversifying supplier bases. Pharmaceutical companies must prioritize quality certifications, supply continuity, and regulatory adherence to maintain drug manufacturing integrity.

---

Key Takeaways

• The primary global source of milrinone lactate API is concentrated in China and India, with a growing emphasis on European and U.S. suppliers for regulatory and quality assurances.
• Due to manufacturing complexity and regulatory scrutiny, selecting suppliers with proven GMP compliance and traceability is essential.
• Supply chain disruptions have prompted diversification efforts; long-term partnerships and strategic procurement are advisable.
• API quality control must align with pharmacopoeial standards, ensuring safety and efficacy for Primacor production.
• Staying vigilant about geopolitical developments and regulatory changes will safeguard uninterrupted API supplies.

---

FAQs

1. What are the major regions supplying milrinone lactate API globally?
China and India are the primary regions, with additional suppliers in Europe and the U.S. focusing on high-quality, compliant production.

2. How does regulatory compliance impact API sourcing for Primacor?
Regulatory adherence ensures API quality, safety, and market access. Certifications like cGMP, FDA DMF, and ISO are critical for supplier qualification.

3. What factors should be considered when selecting an API supplier?
Quality certifications, supply reliability, manufacturing capacity, regulatory compliance, and cost-effectiveness.

4. Are there any recent trends in the API supply market for milrinone lactate?
Yes. There's a trend towards supply chain diversification, increased regulatory scrutiny, and capacity expansion by Indian and Chinese manufacturers.

5. How can manufacturers mitigate risks related to API supply disruptions?
By establishing multiple supplier relationships, maintaining safety stock levels, and engaging in long-term contracts with verified suppliers.

---

Sources
[1] International Pharmaceutical API Market Reports, 2022.
[2] Chinese Pharmaceutical Industry Data, 2021.
[3] Indian API Manufacturers Directory, 2022.
[4] Regulatory guidelines on API manufacturing standards (FDA, EMA, PMDA).